Aleafia Health (OTCQX: ALEAF), a wholly owned subsidiary of Aleafia Farms Inc, announced that the Company’s Ontario–based Niagara Production Facility, has obtained a crucial Health Canada Cultivation License. The license, which is valid until 2023, will enable the Company to cultivate, process and sells its...
Zosano Pharma (NASDAQ: ZSAN), a clinical-stage biopharmaceutical Company, announced the acceptance of the Company’s New Drug Application for Qtrypta™, a proprietary formulation of Zolmitriptan by the U.S Food and Drug Administration (FDA) for filing and substantive review. The FDA has set a The Prescription Drug...
Holiday season beings cheers to not only consumers but also to Companies, which try to make the most of the season by offering products, services and discounts to entice customers to make a purchase. The increase in disposable incomes and a consequent rise in spending...
Aytu BioScience (NASDAQ: AYTU), a specialty pharmaceutical Company engaged in developing solutions for unmet needs in areas such as virility, reproductive health, severe cough and insomnia, has entered into a definitive agreement with Innovus Pharmaceuticals (OTCQB: INNV) for acquisition of the company. The deal is...
